D
HUTCHMED (China) Limited
HMDCF
$3.21
-$0.61-15.99%
D
Sell
3/20/2025Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D from E+ on 3/20/2025 due to a substantial increase in the efficiency index, valuation index and solvency index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D from E+ on 3/20/2025 due to a substantial increase in the efficiency index, valuation index and solvency index.
E
Sell
3/7/2025Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 3/7/2025 due to a decline in the total return index and volatility index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 3/7/2025 due to a decline in the total return index and volatility index.
D
Sell
2/19/2025Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 2/19/2025 due to an increase in the volatility index and growth index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 2/19/2025 due to an increase in the volatility index and growth index.
E
Sell
1/28/2025Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 1/28/2025 due to a decline in the volatility index and total return index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 1/28/2025 due to a decline in the volatility index and total return index.
D
Sell
1/13/2025Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 1/13/2025 due to an increase in the volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 1/13/2025 due to an increase in the volatility index and valuation index.
E
Sell
12/13/2024Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to E+ from E- on 12/13/2024 due to an increase in the volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was upgraded to E+ from E- on 12/13/2024 due to an increase in the volatility index and valuation index.
E
Sell
11/4/2024Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E- from E+ on 11/4/2024 due to a decline in the volatility index and growth index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E- from E+ on 11/4/2024 due to a decline in the volatility index and growth index.
E
Sell
10/7/2024Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 10/7/2024 due to a decline in the volatility index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 10/7/2024 due to a decline in the volatility index.
D
Sell
9/20/2024Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 9/20/2024 due to an increase in the volatility index and total return index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 9/20/2024 due to an increase in the volatility index and total return index.
E
Sell
9/5/2024Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 9/5/2024 due to a decline in the volatility index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 9/5/2024 due to a decline in the volatility index.
D
Sell
8/5/2024Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to D- from D+ on 8/5/2024 due to a substantial decline in the efficiency index, valuation index and growth index.
HUTCHMED (China) Limited (HMDCF) was downgraded to D- from D+ on 8/5/2024 due to a substantial decline in the efficiency index, valuation index and growth index.
D
Sell
3/4/2024Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D+ from D- on 3/4/2024 due to a substantial increase in the efficiency index, valuation index and total return index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D+ from D- on 3/4/2024 due to a substantial increase in the efficiency index, valuation index and total return index.
D
Sell
1/16/2024Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 1/16/2024 due to a noticeable increase in the total return index, volatility index and growth index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 1/16/2024 due to a noticeable increase in the total return index, volatility index and growth index.
E
Sell
9/12/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 9/12/2023 due to a decline in the volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 9/12/2023 due to a decline in the volatility index and valuation index.
D
Sell
8/28/2023Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 8/28/2023 due to an increase in the volatility index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 8/28/2023 due to an increase in the volatility index.
E
Sell
8/2/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 8/2/2023 due to a decline in the valuation index, volatility index and total return index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 8/2/2023 due to a decline in the valuation index, volatility index and total return index.
D
Sell
7/10/2023Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 7/10/2023 due to an increase in the volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 7/10/2023 due to an increase in the volatility index and valuation index.
E
Sell
6/21/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 6/21/2023 due to a decline in the volatility index, valuation index and total return index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 6/21/2023 due to a decline in the volatility index, valuation index and total return index.
D
Sell
6/2/2023Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 6/2/2023 due to an increase in the valuation index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 6/2/2023 due to an increase in the valuation index.
E
Sell
5/17/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 5/17/2023 due to a decline in the valuation index, volatility index and growth index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 5/17/2023 due to a decline in the valuation index, volatility index and growth index.
D
Sell
4/4/2023Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 4/4/2023 due to an increase in the volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 4/4/2023 due to an increase in the volatility index and valuation index.
E
Sell
3/14/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the valuation index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 3/14/2023 due to a decline in the valuation index.
D
Sell
3/2/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to D- from D on 3/2/2023 due to a decline in the solvency index, volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was downgraded to D- from D on 3/2/2023 due to a decline in the solvency index, volatility index and valuation index.
D
Sell
2/13/2023Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D from E+ on 2/13/2023 due to an increase in the volatility index and total return index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D from E+ on 2/13/2023 due to an increase in the volatility index and total return index.
E
Sell
2/8/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 2/8/2023 due to a decline in the volatility index.
D
Sell
1/30/2023Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to D- from D on 1/30/2023 due to a decline in the volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was downgraded to D- from D on 1/30/2023 due to a decline in the volatility index and valuation index.
D
Sell
1/13/2023Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D from D- on 1/13/2023 due to a large increase in the volatility index and total return index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D from D- on 1/13/2023 due to a large increase in the volatility index and total return index.
D
Sell
12/22/2022Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 12/22/2022 due to an increase in the volatility index and total return index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 12/22/2022 due to an increase in the volatility index and total return index.
E
Sell
12/7/2022Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 12/7/2022 due to a decline in the total return index, volatility index and valuation index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 12/7/2022 due to a decline in the total return index, volatility index and valuation index.
D
Sell
11/17/2022Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 11/17/2022 due to an increase in the volatility index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E+ on 11/17/2022 due to an increase in the volatility index.
E
Sell
11/2/2022Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 11/2/2022 due to a decline in the total return index and volatility index.
HUTCHMED (China) Limited (HMDCF) was downgraded to E+ from D- on 11/2/2022 due to a decline in the total return index and volatility index.
D
Sell
8/31/2022Upgraded
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E- on 8/31/2022 due to a noticeable increase in the growth index, total return index and valuation index.
HUTCHMED (China) Limited (HMDCF) was upgraded to D- from E- on 8/31/2022 due to a noticeable increase in the growth index, total return index and valuation index.
E
Sell
1/4/2021Downgrade
HUTCHMED (China) Limited (HMDCF) was downgraded to E- from E+ on 01/04/2021.
HUTCHMED (China) Limited (HMDCF) was downgraded to E- from E+ on 01/04/2021.
E
Sell
7/31/2020Downgrade
Hutchison China MediTech Limited (HNCMF) was downgraded to E+ from D- on 7/31/2020 due to a noticeable decline in the growth index and valuation index.
Hutchison China MediTech Limited (HNCMF) was downgraded to E+ from D- on 7/31/2020 due to a noticeable decline in the growth index and valuation index.
D
Sell
7/16/2020Upgraded
Hutchison China MediTech Limited (HNCMF) was upgraded to D- from E+ on 7/16/2020 due to an increase in the volatility index and total return index.
Hutchison China MediTech Limited (HNCMF) was upgraded to D- from E+ on 7/16/2020 due to an increase in the volatility index and total return index.
E
Sell
4/2/2020Downgrade
Hutchison China MediTech Limited (HNCMF) was downgraded to E+ from D- on 4/2/2020 due to a major decline in the total return index, volatility index and efficiency index.
Hutchison China MediTech Limited (HNCMF) was downgraded to E+ from D- on 4/2/2020 due to a major decline in the total return index, volatility index and efficiency index.
D
Sell
1/8/2020Downgrade
Hutchison China MediTech Limited (HNCMF) was downgraded to D- from D on 1/8/2020 due to a major decline in the volatility index, total return index and efficiency index. Net income declined 28.16% from -$19.89M to -$25.48M, and total capital declined 12.13% from $433.41M to $380.86M.
Hutchison China MediTech Limited (HNCMF) was downgraded to D- from D on 1/8/2020 due to a major decline in the volatility index, total return index and efficiency index. Net income declined 28.16% from -$19.89M to -$25.48M, and total capital declined 12.13% from $433.41M to $380.86M.
D
Sell
6/7/2019Downgrade
Hutchison China MediTech Limited (HNCMF) was downgraded to D from D+ on 6/7/2019 due to a noticeable decline in the growth index, valuation index and efficiency index. Operating cash flow declined 305.91% from -$7.13M to -$28.92M, EBIT declined 85.07% from -$19.48M to -$36.05M, and total revenue declined 6.78% from $55.96M to $52.17M.
Hutchison China MediTech Limited (HNCMF) was downgraded to D from D+ on 6/7/2019 due to a noticeable decline in the growth index, valuation index and efficiency index. Operating cash flow declined 305.91% from -$7.13M to -$28.92M, EBIT declined 85.07% from -$19.48M to -$36.05M, and total revenue declined 6.78% from $55.96M to $52.17M.
D
Sell
5/17/2019Upgraded
Hutchison China MediTech Limited (HNCMF) was upgraded to D+ from D on 5/17/2019 due to an increase in the growth index, volatility index and valuation index.
Hutchison China MediTech Limited (HNCMF) was upgraded to D+ from D on 5/17/2019 due to an increase in the growth index, volatility index and valuation index.
D
Sell
1/8/2019Downgrade
Hutchison China MediTech Limited (HNCMF) was downgraded to D from D+ on 1/8/2019 due to a significant decline in the total return index, volatility index and growth index.
Hutchison China MediTech Limited (HNCMF) was downgraded to D from D+ on 1/8/2019 due to a significant decline in the total return index, volatility index and growth index.
D
Sell
5/1/2018Downgrade
Hutchison China MediTech Limited (HNCMF) was downgraded to D+ from C- on 5/1/2018 due to a decline in the total return index.
Hutchison China MediTech Limited (HNCMF) was downgraded to D+ from C- on 5/1/2018 due to a decline in the total return index.
C
Hold
4/2/2018Downgrade
Hutchison China MediTech Limited (HNCMF) was downgraded to C- from C on 4/2/2018 due to a noticeable decline in the efficiency index and growth index.
Hutchison China MediTech Limited (HNCMF) was downgraded to C- from C on 4/2/2018 due to a noticeable decline in the efficiency index and growth index.
C
Hold
9/26/2017Upgraded
Hutchison China MediTech Limited (HNCMF) was upgraded to C from C- on 9/26/2017 due to a major increase in the total return index.
Hutchison China MediTech Limited (HNCMF) was upgraded to C from C- on 9/26/2017 due to a major increase in the total return index.
C
Hold
8/31/2017Upgraded
Hutchison China MediTech Limited (HNCMF) was upgraded to C- from E on 8/31/2017 due to a noticeable increase in the efficiency index, solvency index and valuation index.
Hutchison China MediTech Limited (HNCMF) was upgraded to C- from E on 8/31/2017 due to a noticeable increase in the efficiency index, solvency index and valuation index.
E
Sell
6/1/2016Downgrade
Hutchison China MediTech Ltd. (HNCMF) was downgraded to E from D+ on 6/1/2016 due to a decline in the total return index.
Hutchison China MediTech Ltd. (HNCMF) was downgraded to E from D+ on 6/1/2016 due to a decline in the total return index.
D
Sell
3/11/2016None
HUTCHMED (China) Limited (HMDCF) was downgraded to D+ from U on 03/11/2016.
HUTCHMED (China) Limited (HMDCF) was downgraded to D+ from U on 03/11/2016.
OTC PK
12/13/2024 2:06PM Eastern
Quotes delayed
